Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
Titel:
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
Auteur:
Wang, Yeming Zhong, Wu Salam, Alex Tarning, Joel Zhan, Qingyuan Huang, Jian-an Weng, Heng Bai, Changqing Ren, Yanhong Yamada, Koichi Wang, Dayan Guo, Qiang Fang, Qiongqiong Tsutomu, Sakurai Zou, Xiaohui Li, Haibo Gillesen, Annelies Castle, Lyndsey Chen, Cheng Li, Hongyan Zhen, Jing Lu, Binghuai Duan, Jun Guo, Liping Jiang, Jinfang Cao, Ruiyuan Fan, Guohui Li, Jintong Hayden, Frederick G. Wang, Chen Horby, Peter Cao, Bin